![Carl Kraus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carl Kraus
Hoofd Techniek/Wetenschap/O&O bij
i3 Research, Inc.
Vermogen: 1 M $ op 31-05-2026
Profiel
Carl N.
Kraus was the founder of Arrevus, Inc., founded in 2015, where the titles held included Chairman, President & Chief Executive Officer from 2017 to 2021.
The current job is Medical Director at i3 Research, Inc. Former jobs include Chief Medical Officer at Idera Pharmaceuticals, Inc., Chief Medical Officer at Resilience Government Services, Inc., Chief Medical Officer at Aceragen, Inc. from 2021 to 2023, and Chief Medical Officer at Aquestive Therapeutics, Inc. from 2023 to 2025.
Education includes undergraduate studies at Washington University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-10-2025 | 282.475 ( 0,23% ) | 1 M $ | 31-05-2026 |
Actieve functies van Carl Kraus
| Bedrijven | Functie | Begin |
|---|---|---|
i3 Research, Inc.
 i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts oncology, central nervous system, and respiratory research | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Carl Kraus
| Bedrijven | Functie | Einde |
|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 04-11-2025 |
| ACERAGEN, INC. | Hoofd Techniek/Wetenschap/O&O | 30-04-2023 |
Arrevus, Inc.
 Arrevus, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for orphan infectious diseases | Algemeen Directeur | 31-10-2021 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Hoofd Techniek/Wetenschap/O&O | - |
Resilience Government Services, Inc.
 Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Operates as an integrated biopharmaceutical company | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Carl Kraus
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
5
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Aquestive Therapeutics, Inc.
 Aquestive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes thin film pharmaceutical and over the counter drug products | Health Technology |
i3 Research, Inc.
i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts oncology, central nervous system, and respiratory research | Commercial Services |
Resilience Government Services, Inc.
Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Operates as an integrated biopharmaceutical company | Health Technology |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arrevus, Inc.
Arrevus, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for orphan infectious diseases | Health Technology |
Aceragen, Inc.
 Aceragen, Inc. BiotechnologyHealth Technology Discovers, develops, and commercializes therapeutics for oncology and rare diseases | Health Technology |
